Literature DB >> 10823414

Selective impairments in the stress response in schizophrenic patients.

L M Jansen1, C C Gispen-de Wied, R S Kahn.   

Abstract

OBJECTIVE: In the vulnerability-stress concept of schizophrenia, schizophrenic patients are thought to display increased sensitivity to stress. Little is known about the biological mechanisms that are involved in stress processing in schizophrenic patients. In this study, hypothalarnic-pituitary-adrenal (HPA) function in schizophrenic patients was studied for its essential role in stress processing and adaptation to the environment.
METHODS: Eighteen schizophrenic patients were compared to 21 healthy controls in their salivary cortisol response to a physical (bicycle ergometry) and a psychosocial (public speaking) stressor. Coping questionnaires were included as a measure of stress processing at the psychological level. Basal HPA function was assessed by measuring cortisol day profiles and feedback activity by using dexamethasone and hydrocortisone.
RESULTS: Schizophrenic patients showed blunted cortisol responses to the psychosocial stressor, but not to the physical stressor, in spite of similar increases in heart rate. The cortisol response to the psychosocial stressor tended to be negatively correlated to the use of passive and avoidant coping strategies. Basal HPA function appeared intact in the schizophrenic patients.
CONCLUSIONS: The findings show a selective impairment in the response to psychosocial stress in schizophrenic patients. This suggests the involvement of brain systems that play a role in the activation of the HPA system to psycho-social stress, like arginin-vasopressin (AVP), and cognitive processes, like coping.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823414     DOI: 10.1007/s002130000381

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

Review 1.  The stress-vulnerability hypothesis in psychotic disorders: focus on the stress response systems.

Authors:  Christine C Gispen-de Wied; Lucres M C Jansen
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 2.  A new look at the neural diathesis--stress model of schizophrenia: the primacy of social-evaluative and uncontrollable situations.

Authors:  Simon R Jones; Charles Fernyhough
Journal:  Schizophr Bull       Date:  2006-11-14       Impact factor: 9.306

3.  Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task.

Authors:  Ee Peng Lim; Vivek Verma; Rajini Nagarajah; Gavin S Dawe
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

4.  Cortisol response to an experimental stress paradigm prospectively predicts long-term distress and resilience trajectories in response to active police service.

Authors:  Isaac R Galatzer-Levy; Maria M Steenkamp; Adam D Brown; Meng Qian; Sabra Inslicht; Clare Henn-Haase; Christian Otte; Rachel Yehuda; Thomas C Neylan; Charles R Marmar
Journal:  J Psychiatr Res       Date:  2014-05-14       Impact factor: 4.791

5.  Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness.

Authors:  Duncan Sinclair; Shan Yuan Tsai; Heng Giap Woon; Cynthia Shannon Weickert
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

6.  Cortisol Reactivity to Stress and Its Association With White Matter Integrity in Adults With Schizophrenia.

Authors:  Katie L Nugent; Joshua Chiappelli; Hemalatha Sampath; Laura M Rowland; Kavita Thangavelu; Beshaun Davis; Xiaoming Du; Florian Muellerklein; Stacey Daughters; Peter Kochunov; L Elliot Hong
Journal:  Psychosom Med       Date:  2015-09       Impact factor: 4.312

Review 7.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

8.  Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice.

Authors:  Christina L Bodarky; Tobias B Halene; Richard S Ehrlichman; Anamika Banerjee; Rabindranath Ray; Chang-Gyu Hahn; Gerald Jonak; Steven J Siegel
Journal:  J Pharmacol Exp Ther       Date:  2009-07-14       Impact factor: 4.030

9.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

10.  Emotion awareness and regulation in individuals with schizophrenia: Implications for social functioning.

Authors:  David Kimhy; Julia Vakhrusheva; Lauren Jobson-Ahmed; Nicholas Tarrier; Dolores Malaspina; James J Gross
Journal:  Psychiatry Res       Date:  2012-06-30       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.